Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00441142
What this trial is testing

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Patrick Y. Wen, MD 119
Testing effectiveness (Phase 2)Study completedNCT01062399
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 279
Testing effectiveness (Phase 2)Study completedNCT00003751
What this trial is testing

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Testing effectiveness (Phase 2)Study completedNCT01220271
What this trial is testing

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioma
Eli Lilly and Company 75
Early research (Phase 1)Looking for participantsNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Not applicableWithdrawnNCT04218019
What this trial is testing

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

Who this might be right for
Newly Diagnosed Glioblastoma in Patients ≥70 Years
Juergen Debus
Testing effectiveness (Phase 2)Study completedNCT03463265
What this trial is testing

Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

Who this might be right for
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
Aadi Bioscience, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT00905060
What this trial is testing

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 70
Early research (Phase 1)Study completedNCT06665724
What this trial is testing

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Who this might be right for
Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Glioblastoma (GBM)
Universität Münster 16
Testing effectiveness (Phase 2)Study completedNCT03174197
What this trial is testing

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Early research (Phase 1)Ended earlyNCT01702792
What this trial is testing

Derivation of Tumor Specific Hybridomas

Who this might be right for
Glioblastoma
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT05074992
What this trial is testing

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University College, London 1
Early research (Phase 1)Study completedNCT02270034
What this trial is testing

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme (Grade IV) of Cerebellum
Grupo Español de Investigación en Neurooncología 38
Testing effectiveness (Phase 2)WithdrawnNCT03506139
What this trial is testing

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
John M. Buatti
Testing effectiveness (Phase 2)UnknownNCT06186440
What this trial is testing

Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Zhongnan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00200161
What this trial is testing

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Who this might be right for
GlioblastomaGliomas
Memorial Sloan Kettering Cancer Center 127
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Next Page